Who owns Galectin Therapeutics?
- Ticker: GALT
- CUSIP Number: 363225202
Tip: Access positions for across all investors
Analyze quarterly positions in Galectin Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Galectin Therapeutics stock
Who bought or sold Galectin Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Capital Management | 2.0M | $5.5M | 100% | Mar 2026 |
|
| Marshall Wace | 1.2M | $3.4M | 103% | Mar 2026 |
|
| Advisor Group Holdings | 1.1M | $3.1M | 3% | Mar 2026 |
|
| Susquehanna International | 1.1M | $3.0M | 22% | Mar 2026 |
|
| Dr. Jeffrey R. Jay, M.D. | 800k | $2.2M | 100% | Mar 2026 |
|
| BlackRock | 799k | $2.2M | 0% | Mar 2026 |
|
| Millennium Management | 798k | $2.2M | 239% | Mar 2026 |
|
| Sontag Advisory | 722k | $2.0M | 20% | Mar 2026 |
|
| Geode Capital Management | 613k | $1.7M | 2% | Mar 2026 |
|
| Two Sigma Investments | 467k | $1.3M | 2712% | Mar 2026 |
|
| Commonwealth Equity Services | 367k | $1.0M | 10% | Mar 2026 |
|
| Citadel Advisors | 363k | $1.0M | 1221% | Mar 2026 |
|
| Jane Street | 362k | $1.0M | -5% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 304k | $849k | 100% | Mar 2026 |
|
| LPL Financial | 267k | $746k | -18% | Mar 2026 |
|
| Vivaldi Capital Management | 259k | $721k | 27% | Mar 2026 |
|
| State Street Corporation | 258k | $721k | 7% | Mar 2026 |
|
| Sovran Advisors | 258k | $585k | 14% | Mar 2026 |
|
| Geneos Wealth Management | 241k | $672k | -1% | Mar 2026 |
|
| Retirement Guys Formula | 187k | $522k | 1% | Mar 2026 |
|
| Goldman Sachs Group | 185k | $515k | -40% | Mar 2026 |
|
| UBS Group | 180k | $501k | 360% | Mar 2026 |
|
| 683 Capital Management | 163k | $453k | 0% | Mar 2026 |
|
| William Blair $ Company | 149k | $417k | 294% | Mar 2026 |
|
| Renaissance Technologies | 148k | $413k | 100% | Mar 2026 |
|
| Northern Trust | 130k | $364k | 0% | Mar 2026 |
|
| Cambridge Investment Research Advisors | 129k | $359k | 2% | Mar 2026 |
|
| Qube Research & Technologies | 126k | $353k | 69% | Mar 2026 |
|
| Barclays | 112k | $312k | 5% | Mar 2026 |
|
| Belpointe Asset Management | 106k | $296k | 0% | Mar 2026 |
|
| Fortis Capital Advisors | 106k | $296k | 0% | Mar 2026 |
|
| Morgan Stanley | 104k | $291k | -63% | Mar 2026 |
|
| HighTower Advisors | 93k | $261k | 6% | Mar 2026 |
|
| Simplex Trading | 84k | $234k | 1406% | Mar 2026 |
|
| Hudson Bay Capital Management | 75k | $209k | -4% | Mar 2026 |
|
| GSA Capital Partners | 71k | $199k | -30% | Mar 2026 |
|
| Branch Banking & Trust Company | 68k | $316k | 0% | Jun 2026 |
|
| Bank of America Corporation | 54k | $150k | 100% | Mar 2026 |
|
| Hrt Financial | 51k | $142k | 100% | Mar 2026 |
|
| Horizon Kinetics Asset Management | 49k | $137k | -4% | Mar 2026 |
|
| Sanctuary Advisors | 43k | $121k | -5% | Mar 2026 |
|
| Pinnacle Financial Partners | 42k | $116k | -13% | Mar 2026 |
|
| Wiley Bros.-aintree Capital | 41k | $114k | 100% | Mar 2026 |
|
| Caption Management | 40k | $112k | 100% | Mar 2026 |
|
| Brevan Howard Capital Management | 36k | $99k | 100% | Mar 2026 |
|
| Charles Schwab Investment Management | 30k | $84k | 0% | Mar 2026 |
|
| Pekin, Singer Strauss Asset Management | 30k | $84k | 100% | Mar 2026 |
|
| Solutions 4 Wealth | 25k | $70k | -1% | Mar 2026 |
|
| OMERS Administration Corporation | 24k | $67k | -62% | Mar 2026 |
|
| Gladstone Institutional Advisory | 24k | $111k | 0% | Jun 2026 |
|
| Invesco | 24k | $66k | 131% | Mar 2026 |
|
| Catalyst Funds Management Pty | 23k | $63k | 100% | Mar 2026 |
|
| Citigroup | 22k | $62k | 100% | Mar 2026 |
|
| Inspire Advisors | 21k | $59k | 0% | Mar 2026 |
|
| Cahaba Wealth Management | 21k | $59k | 0% | Mar 2026 |
|
| Summit Trail Advisors | 20k | $56k | 0% | Mar 2026 |
|
| Stratos Wealth Partners | 20k | $56k | 4% | Mar 2026 |
|
| Mariner Wealth Advisors | 20k | $55k | 0% | Mar 2026 |
|
| Nine Masts Capital | 19k | $54k | 100% | Mar 2026 |
|
| Engineers Gate Manager | 19k | $52k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 18k | $50k | 100% | Mar 2026 |
|
| Diametric Capital | 17k | $48k | 100% | Mar 2026 |
|
| Raymond James Financial | 15k | $42k | 9% | Mar 2026 |
|
| Virtu Financial | 15k | $42k | -72% | Mar 2026 |
|
| Cetera Investment Advisers | 14k | $40k | 0% | Mar 2026 |
|
| Colony | 14k | $39k | 10% | Mar 2026 |
|
| Sig Brokerage | 14k | $38k | 0% | Mar 2026 |
|
| Archer Investment Corp | 14k | $38k | 5% | Mar 2026 |
|
| Argyle Capital Partners | 13k | $37k | 0% | Mar 2026 |
|
| FMR | 13k | $36k | 1% | Mar 2026 |
|
| Leucadia National Corporation | 12k | $34k | -26% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 12k | $33k | -13% | Mar 2026 |
|
| Stock Yards Trust Company | 11k | $29k | 0% | Mar 2026 |
|
| Creative Planning | 11k | $29k | -7% | Mar 2026 |
|
| Mercer Global Advisors | 10k | $28k | 100% | Mar 2026 |
|
| Atwood & Palmer | 10k | $46k | 0% | Jun 2026 |
|
| Integrated Wealth Concepts | 10k | $28k | 100% | Mar 2026 |
|
| Ronald Blue Trust | 7.0k | $20k | 0% | Mar 2026 |
|
| Wells Fargo & Company | 6.3k | $18k | 54% | Mar 2026 |
|
| Hartland & Co | 6.0k | $17k | -25% | Mar 2026 |
|
| Tower Research Capital | 4.4k | $12k | -27% | Mar 2026 |
|
| Rockefeller Capital Management | 4.4k | $12k | 0% | Mar 2026 |
|
| CoreCap Advisors | 3.9k | $18k | -15% | Jun 2026 |
|
| Sound Income Strategies | 3.0k | $8.0k | 0% | Mar 2026 |
|
| Activest Wealth Management | 2.0k | $9.3k | 0% | Jun 2026 |
|
| Northwestern Mutual Wealth Management Company | 1.9k | $5.3k | 214% | Mar 2026 |
|
| Royal Bank of Canada | 1.1k | $3.2k | 100% | Mar 2026 |
|
| MAI Wealth Advisors | 1.0k | $2.8k | 0% | Mar 2026 |
|
| Jones Financial Companies, L.L | 1.0k | $2.7k | 100% | Mar 2026 |
|
| Hilton Head Capital Partners | 800.00 | $2.2k | 100% | Mar 2026 |
|
| NISA Investment Advisors | 716.00 | $2.0k | 0% | Mar 2026 |
|
| Sterling Capital Management | 417.00 | $1.9k | 100% | Jun 2026 |
|
| Salem Investment Counselors | 167.00 | $465.996800 | 100% | Mar 2026 |
|
| Russell Investments | 142.00 | $395.995400 | -99% | Mar 2026 |
|
| CWM | 139.00 | $388.004600 | -55% | Mar 2026 |
|
| Hamrick Investment Counsel | 100.00 | $279.000000 | 100% | Mar 2026 |
|
| Optiver Holding B.V. | 18.00 | $50.000400 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 7.00 | $19.999700 | 100% | Mar 2026 |
|
Who sold out of Galectin Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Wellington Management Company | Dec 2025 | 142k | $592k |
| Traynor Capital Management | Dec 2025 | 102k | $423k |
| ExodusPoint Capital Management | Dec 2025 | 83k | $343k |
| XTX Topco | Dec 2025 | 52k | $216k |
| Lido Advisors | Dec 2025 | 36k | $154k |
| Wealth Enhancement Advisory Services | Dec 2025 | 35k | $122k |
| Tulsa Wealth Advisors | Dec 2025 | 23k | $97k |
| Balyasny Asset Management | Dec 2025 | 22k | $90k |
| Lighthouse Investment Partners | Dec 2025 | 19k | $79k |
| Mangrove Partners | Dec 2025 | 19k | $78k |
| Squarepoint Ops | Dec 2025 | 17k | $69k |
| Harbour Investments | Dec 2025 | 150.00 | $624.000000 |
| Fortitude Family Office | Dec 2025 | 90.00 | $374.004000 |